nodes	percent_of_prediction	percent_of_DWPC	metapath
Adinazolam—GABRR3—nerve—hypothyroidism	0.0964	0.11	CbGeAlD
Adinazolam—GABRR2—nerve—hypothyroidism	0.0836	0.095	CbGeAlD
Adinazolam—GABRR1—nerve—hypothyroidism	0.0804	0.0914	CbGeAlD
Adinazolam—CYP2C19—urine—hypothyroidism	0.0475	0.0539	CbGeAlD
Adinazolam—CYP3A4—urine—hypothyroidism	0.0281	0.0319	CbGeAlD
Adinazolam—GABRG3—pituitary gland—hypothyroidism	0.0262	0.0298	CbGeAlD
Adinazolam—GABRA4—heart—hypothyroidism	0.0219	0.0248	CbGeAlD
Adinazolam—GABRB1—pituitary gland—hypothyroidism	0.0202	0.023	CbGeAlD
Adinazolam—GABRG3—testis—hypothyroidism	0.0193	0.022	CbGeAlD
Adinazolam—GABRR1—testis—hypothyroidism	0.0184	0.0209	CbGeAlD
Adinazolam—GABRA4—pituitary gland—hypothyroidism	0.0183	0.0208	CbGeAlD
Adinazolam—GABRP—pituitary gland—hypothyroidism	0.0181	0.0206	CbGeAlD
Adinazolam—GABRR2—cerebellum—hypothyroidism	0.0177	0.0201	CbGeAlD
Adinazolam—GABRE—heart—hypothyroidism	0.0166	0.0188	CbGeAlD
Adinazolam—GABRA3—thyroid gland—hypothyroidism	0.0162	0.0184	CbGeAlD
Adinazolam—GABRD—testis—hypothyroidism	0.016	0.0182	CbGeAlD
Adinazolam—GABRG2—pituitary gland—hypothyroidism	0.0153	0.0174	CbGeAlD
Adinazolam—GABRA5—testis—hypothyroidism	0.0149	0.0169	CbGeAlD
Adinazolam—GABRD—cerebellum—hypothyroidism	0.0148	0.0168	CbGeAlD
Adinazolam—GABRG1—cerebellum—hypothyroidism	0.0142	0.0162	CbGeAlD
Adinazolam—GABRA6—cerebellum—hypothyroidism	0.0142	0.0161	CbGeAlD
Adinazolam—GABRB3—heart—hypothyroidism	0.014	0.016	CbGeAlD
Adinazolam—GABRA3—testis—hypothyroidism	0.0138	0.0157	CbGeAlD
Adinazolam—GABRE—pituitary gland—hypothyroidism	0.0138	0.0157	CbGeAlD
Adinazolam—GABRB1—cerebellum—hypothyroidism	0.0138	0.0157	CbGeAlD
Adinazolam—GABRA2—adrenal gland—hypothyroidism	0.0125	0.0142	CbGeAlD
Adinazolam—GABRA4—cerebellum—hypothyroidism	0.0125	0.0142	CbGeAlD
Adinazolam—GABRE—adrenal gland—hypothyroidism	0.0124	0.0141	CbGeAlD
Adinazolam—GABRB3—gonad—hypothyroidism	0.012	0.0137	CbGeAlD
Adinazolam—GABRE—thyroid gland—hypothyroidism	0.0119	0.0136	CbGeAlD
Adinazolam—GABRB3—pituitary gland—hypothyroidism	0.0117	0.0133	CbGeAlD
Adinazolam—GABRE—female gonad—hypothyroidism	0.0115	0.0131	CbGeAlD
Adinazolam—GABRB2—testis—hypothyroidism	0.0113	0.0128	CbGeAlD
Adinazolam—GABRB2—cerebellum—hypothyroidism	0.0104	0.0118	CbGeAlD
Adinazolam—GABRG2—cerebellum—hypothyroidism	0.0104	0.0118	CbGeAlD
Adinazolam—GABRE—testis—hypothyroidism	0.0102	0.0116	CbGeAlD
Adinazolam—GABRB3—thyroid gland—hypothyroidism	0.0101	0.0115	CbGeAlD
Adinazolam—GABRA2—cerebellum—hypothyroidism	0.00952	0.0108	CbGeAlD
Adinazolam—GABRA1—cerebellum—hypothyroidism	0.0092	0.0105	CbGeAlD
Adinazolam—CYP2C19—blood—hypothyroidism	0.00907	0.0103	CbGeAlD
Adinazolam—GABRB3—testis—hypothyroidism	0.00867	0.00985	CbGeAlD
Adinazolam—GABRB3—liver—hypothyroidism	0.00819	0.00931	CbGeAlD
Adinazolam—GABRB3—cerebellum—hypothyroidism	0.008	0.0091	CbGeAlD
Adinazolam—CYP2C19—liver—hypothyroidism	0.0071	0.00806	CbGeAlD
Adinazolam—CYP3A4—blood—hypothyroidism	0.00536	0.0061	CbGeAlD
Adinazolam—CYP3A4—liver—hypothyroidism	0.00419	0.00477	CbGeAlD
Adinazolam—GABRR1—Transmission across Chemical Synapses—SLC5A7—hypothyroidism	0.00253	0.0211	CbGpPWpGaD
Adinazolam—GABRR2—Transmission across Chemical Synapses—SLC5A7—hypothyroidism	0.00241	0.0201	CbGpPWpGaD
Adinazolam—GABRR1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—NEFL—hypothyroidism	0.00217	0.0181	CbGpPWpGaD
Adinazolam—GABRR2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—NEFL—hypothyroidism	0.00207	0.0172	CbGpPWpGaD
Adinazolam—GABRA1—SIDS Susceptibility Pathways—DLX2—hypothyroidism	0.002	0.0167	CbGpPWpGaD
Adinazolam—GABRG3—Transmission across Chemical Synapses—SLC5A7—hypothyroidism	0.00199	0.0166	CbGpPWpGaD
Adinazolam—GABRB1—Transmission across Chemical Synapses—SLC5A7—hypothyroidism	0.00196	0.0163	CbGpPWpGaD
Adinazolam—GABRR1—Neuronal System—SLC5A7—hypothyroidism	0.00194	0.0162	CbGpPWpGaD
Adinazolam—GABRA6—Transmission across Chemical Synapses—SLC5A7—hypothyroidism	0.00185	0.0154	CbGpPWpGaD
Adinazolam—GABRR2—Neuronal System—SLC5A7—hypothyroidism	0.00185	0.0154	CbGpPWpGaD
Adinazolam—GABRA4—Transmission across Chemical Synapses—SLC5A7—hypothyroidism	0.00183	0.0152	CbGpPWpGaD
Adinazolam—GABRG3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—NEFL—hypothyroidism	0.0017	0.0142	CbGpPWpGaD
Adinazolam—GABRB1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—NEFL—hypothyroidism	0.00168	0.014	CbGpPWpGaD
Adinazolam—GABRB2—Transmission across Chemical Synapses—SLC5A7—hypothyroidism	0.00167	0.0139	CbGpPWpGaD
Adinazolam—GABRR1—Transmission across Chemical Synapses—NEFL—hypothyroidism	0.00163	0.0136	CbGpPWpGaD
Adinazolam—GABRA5—Transmission across Chemical Synapses—SLC5A7—hypothyroidism	0.00163	0.0135	CbGpPWpGaD
Adinazolam—GABRA3—Transmission across Chemical Synapses—SLC5A7—hypothyroidism	0.0016	0.0133	CbGpPWpGaD
Adinazolam—GABRA6—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—NEFL—hypothyroidism	0.00159	0.0132	CbGpPWpGaD
Adinazolam—GABRA2—Transmission across Chemical Synapses—SLC5A7—hypothyroidism	0.00157	0.0131	CbGpPWpGaD
Adinazolam—GABRA4—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—NEFL—hypothyroidism	0.00157	0.0131	CbGpPWpGaD
Adinazolam—GABRB3—Transmission across Chemical Synapses—SLC5A7—hypothyroidism	0.00156	0.013	CbGpPWpGaD
Adinazolam—GABRR2—Transmission across Chemical Synapses—NEFL—hypothyroidism	0.00156	0.013	CbGpPWpGaD
Adinazolam—GABRG2—Transmission across Chemical Synapses—SLC5A7—hypothyroidism	0.00153	0.0128	CbGpPWpGaD
Adinazolam—GABRG3—Neuronal System—SLC5A7—hypothyroidism	0.00152	0.0127	CbGpPWpGaD
Adinazolam—GABRB1—Neuronal System—SLC5A7—hypothyroidism	0.0015	0.0125	CbGpPWpGaD
Adinazolam—GABRB2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—NEFL—hypothyroidism	0.00143	0.012	CbGpPWpGaD
Adinazolam—GABRA6—Neuronal System—SLC5A7—hypothyroidism	0.00142	0.0118	CbGpPWpGaD
Adinazolam—GABRA4—Neuronal System—SLC5A7—hypothyroidism	0.0014	0.0117	CbGpPWpGaD
Adinazolam—GABRA5—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—NEFL—hypothyroidism	0.00139	0.0116	CbGpPWpGaD
Adinazolam—GABRA3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—NEFL—hypothyroidism	0.00137	0.0114	CbGpPWpGaD
Adinazolam—GABRA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—NEFL—hypothyroidism	0.00134	0.0112	CbGpPWpGaD
Adinazolam—GABRA1—Transmission across Chemical Synapses—SLC5A7—hypothyroidism	0.00134	0.0111	CbGpPWpGaD
Adinazolam—GABRB3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—NEFL—hypothyroidism	0.00134	0.0111	CbGpPWpGaD
Adinazolam—GABRG2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—NEFL—hypothyroidism	0.00131	0.0109	CbGpPWpGaD
Adinazolam—GABRA1—SIDS Susceptibility Pathways—THRB—hypothyroidism	0.00129	0.0107	CbGpPWpGaD
Adinazolam—GABRB2—Neuronal System—SLC5A7—hypothyroidism	0.00128	0.0107	CbGpPWpGaD
Adinazolam—GABRG3—Transmission across Chemical Synapses—NEFL—hypothyroidism	0.00128	0.0107	CbGpPWpGaD
Adinazolam—GABRB1—Transmission across Chemical Synapses—NEFL—hypothyroidism	0.00126	0.0105	CbGpPWpGaD
Adinazolam—GABRR1—Neuronal System—NEFL—hypothyroidism	0.00125	0.0104	CbGpPWpGaD
Adinazolam—GABRA5—Neuronal System—SLC5A7—hypothyroidism	0.00125	0.0104	CbGpPWpGaD
Adinazolam—GABRA3—Neuronal System—SLC5A7—hypothyroidism	0.00122	0.0102	CbGpPWpGaD
Adinazolam—GABRA2—Neuronal System—SLC5A7—hypothyroidism	0.0012	0.01	CbGpPWpGaD
Adinazolam—GABRB3—Neuronal System—SLC5A7—hypothyroidism	0.00119	0.00995	CbGpPWpGaD
Adinazolam—GABRA6—Transmission across Chemical Synapses—NEFL—hypothyroidism	0.00119	0.00995	CbGpPWpGaD
Adinazolam—GABRR2—Neuronal System—NEFL—hypothyroidism	0.00119	0.00993	CbGpPWpGaD
Adinazolam—GABRA4—Transmission across Chemical Synapses—NEFL—hypothyroidism	0.00118	0.00982	CbGpPWpGaD
Adinazolam—GABRG2—Neuronal System—SLC5A7—hypothyroidism	0.00117	0.00977	CbGpPWpGaD
Adinazolam—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—NEFL—hypothyroidism	0.00115	0.00956	CbGpPWpGaD
Adinazolam—GABRB2—Transmission across Chemical Synapses—NEFL—hypothyroidism	0.00108	0.00899	CbGpPWpGaD
Adinazolam—GABRA5—Transmission across Chemical Synapses—NEFL—hypothyroidism	0.00105	0.00873	CbGpPWpGaD
Adinazolam—GABRR1—Transmembrane transport of small molecules—SLC5A7—hypothyroidism	0.00104	0.00869	CbGpPWpGaD
Adinazolam—GABRA3—Transmission across Chemical Synapses—NEFL—hypothyroidism	0.00103	0.00857	CbGpPWpGaD
Adinazolam—GABRA1—Neuronal System—SLC5A7—hypothyroidism	0.00103	0.00854	CbGpPWpGaD
Adinazolam—GABRA2—Transmission across Chemical Synapses—NEFL—hypothyroidism	0.00101	0.00842	CbGpPWpGaD
Adinazolam—GABRB3—Transmission across Chemical Synapses—NEFL—hypothyroidism	0.001	0.00837	CbGpPWpGaD
Adinazolam—GABRR2—Transmembrane transport of small molecules—SLC5A7—hypothyroidism	0.000995	0.00829	CbGpPWpGaD
Adinazolam—GABRG2—Transmission across Chemical Synapses—NEFL—hypothyroidism	0.000986	0.00822	CbGpPWpGaD
Adinazolam—GABRG3—Neuronal System—NEFL—hypothyroidism	0.000982	0.00818	CbGpPWpGaD
Adinazolam—GABRB1—Neuronal System—NEFL—hypothyroidism	0.000967	0.00806	CbGpPWpGaD
Adinazolam—GABRA6—Neuronal System—NEFL—hypothyroidism	0.000915	0.00762	CbGpPWpGaD
Adinazolam—GABRA4—Neuronal System—NEFL—hypothyroidism	0.000903	0.00753	CbGpPWpGaD
Adinazolam—GABRR1—Transmembrane transport of small molecules—SLC26A4—hypothyroidism	0.000864	0.0072	CbGpPWpGaD
Adinazolam—GABRA1—Transmission across Chemical Synapses—NEFL—hypothyroidism	0.000862	0.00718	CbGpPWpGaD
Adinazolam—GABRB2—Neuronal System—NEFL—hypothyroidism	0.000826	0.00688	CbGpPWpGaD
Adinazolam—GABRR2—Transmembrane transport of small molecules—SLC26A4—hypothyroidism	0.000824	0.00687	CbGpPWpGaD
Adinazolam—GABRG3—Transmembrane transport of small molecules—SLC5A7—hypothyroidism	0.000819	0.00682	CbGpPWpGaD
Adinazolam—GABRB1—Transmembrane transport of small molecules—SLC5A7—hypothyroidism	0.000807	0.00672	CbGpPWpGaD
Adinazolam—GABRA5—Neuronal System—NEFL—hypothyroidism	0.000803	0.00669	CbGpPWpGaD
Adinazolam—GABRA3—Neuronal System—NEFL—hypothyroidism	0.000788	0.00657	CbGpPWpGaD
Adinazolam—GABRA2—Neuronal System—NEFL—hypothyroidism	0.000775	0.00645	CbGpPWpGaD
Adinazolam—GABRB3—Neuronal System—NEFL—hypothyroidism	0.00077	0.00641	CbGpPWpGaD
Adinazolam—GABRA6—Transmembrane transport of small molecules—SLC5A7—hypothyroidism	0.000763	0.00636	CbGpPWpGaD
Adinazolam—GABRG2—Neuronal System—NEFL—hypothyroidism	0.000756	0.0063	CbGpPWpGaD
Adinazolam—GABRA4—Transmembrane transport of small molecules—SLC5A7—hypothyroidism	0.000754	0.00628	CbGpPWpGaD
Adinazolam—GABRB2—Transmembrane transport of small molecules—SLC5A7—hypothyroidism	0.000689	0.00574	CbGpPWpGaD
Adinazolam—GABRG3—Transmembrane transport of small molecules—SLC26A4—hypothyroidism	0.000679	0.00565	CbGpPWpGaD
Adinazolam—GABRA5—Transmembrane transport of small molecules—SLC5A7—hypothyroidism	0.00067	0.00558	CbGpPWpGaD
Adinazolam—GABRB1—Transmembrane transport of small molecules—SLC26A4—hypothyroidism	0.000668	0.00557	CbGpPWpGaD
Adinazolam—GABRB3—BDNF signaling pathway—VAV3—hypothyroidism	0.000662	0.00552	CbGpPWpGaD
Adinazolam—GABRA1—Neuronal System—NEFL—hypothyroidism	0.000661	0.0055	CbGpPWpGaD
Adinazolam—GABRA3—Transmembrane transport of small molecules—SLC5A7—hypothyroidism	0.000658	0.00548	CbGpPWpGaD
Adinazolam—GABRA2—Transmembrane transport of small molecules—SLC5A7—hypothyroidism	0.000646	0.00539	CbGpPWpGaD
Adinazolam—GABRB3—Transmembrane transport of small molecules—SLC5A7—hypothyroidism	0.000642	0.00535	CbGpPWpGaD
Adinazolam—GABRA6—Transmembrane transport of small molecules—SLC26A4—hypothyroidism	0.000633	0.00527	CbGpPWpGaD
Adinazolam—GABRG2—Transmembrane transport of small molecules—SLC5A7—hypothyroidism	0.000631	0.00525	CbGpPWpGaD
Adinazolam—GABRA4—Transmembrane transport of small molecules—SLC26A4—hypothyroidism	0.000625	0.0052	CbGpPWpGaD
Adinazolam—GABRB2—Transmembrane transport of small molecules—SLC26A4—hypothyroidism	0.000571	0.00476	CbGpPWpGaD
Adinazolam—GABRA5—Transmembrane transport of small molecules—SLC26A4—hypothyroidism	0.000555	0.00462	CbGpPWpGaD
Adinazolam—GABRA1—Transmembrane transport of small molecules—SLC5A7—hypothyroidism	0.000551	0.00459	CbGpPWpGaD
Adinazolam—GABRA3—Transmembrane transport of small molecules—SLC26A4—hypothyroidism	0.000545	0.00454	CbGpPWpGaD
Adinazolam—GABRA2—Transmembrane transport of small molecules—SLC26A4—hypothyroidism	0.000536	0.00446	CbGpPWpGaD
Adinazolam—GABRB3—Transmembrane transport of small molecules—SLC26A4—hypothyroidism	0.000532	0.00443	CbGpPWpGaD
Adinazolam—GABRG2—Transmembrane transport of small molecules—SLC26A4—hypothyroidism	0.000522	0.00435	CbGpPWpGaD
Adinazolam—GABRA1—SIDS Susceptibility Pathways—AVP—hypothyroidism	0.000514	0.00428	CbGpPWpGaD
Adinazolam—GABRA1—Transmembrane transport of small molecules—SLC26A4—hypothyroidism	0.000457	0.00381	CbGpPWpGaD
Adinazolam—GABRR1—Transmembrane transport of small molecules—SLC5A5—hypothyroidism	0.000417	0.00347	CbGpPWpGaD
Adinazolam—GABRR2—Transmembrane transport of small molecules—SLC5A5—hypothyroidism	0.000398	0.00331	CbGpPWpGaD
Adinazolam—CYP2C19—Cytochrome P450 - arranged by substrate type—POMC—hypothyroidism	0.000377	0.00314	CbGpPWpGaD
Adinazolam—GABRR1—Transmembrane transport of small molecules—AVP—hypothyroidism	0.000328	0.00273	CbGpPWpGaD
Adinazolam—GABRG3—Transmembrane transport of small molecules—SLC5A5—hypothyroidism	0.000327	0.00273	CbGpPWpGaD
Adinazolam—GABRB1—Transmembrane transport of small molecules—SLC5A5—hypothyroidism	0.000322	0.00269	CbGpPWpGaD
Adinazolam—GABRR2—Transmembrane transport of small molecules—AVP—hypothyroidism	0.000313	0.00261	CbGpPWpGaD
Adinazolam—CYP2C19—Phase 1 - Functionalization of compounds—POMC—hypothyroidism	0.000305	0.00254	CbGpPWpGaD
Adinazolam—GABRA6—Transmembrane transport of small molecules—SLC5A5—hypothyroidism	0.000305	0.00254	CbGpPWpGaD
Adinazolam—GABRA4—Transmembrane transport of small molecules—SLC5A5—hypothyroidism	0.000301	0.00251	CbGpPWpGaD
Adinazolam—GABRB2—Transmembrane transport of small molecules—SLC5A5—hypothyroidism	0.000276	0.0023	CbGpPWpGaD
Adinazolam—GABRA5—Transmembrane transport of small molecules—SLC5A5—hypothyroidism	0.000268	0.00223	CbGpPWpGaD
Adinazolam—GABRA3—Transmembrane transport of small molecules—SLC5A5—hypothyroidism	0.000263	0.00219	CbGpPWpGaD
Adinazolam—GABRA2—Transmembrane transport of small molecules—SLC5A5—hypothyroidism	0.000258	0.00215	CbGpPWpGaD
Adinazolam—GABRG3—Transmembrane transport of small molecules—AVP—hypothyroidism	0.000258	0.00215	CbGpPWpGaD
Adinazolam—GABRB3—Transmembrane transport of small molecules—SLC5A5—hypothyroidism	0.000257	0.00214	CbGpPWpGaD
Adinazolam—GABRB1—Transmembrane transport of small molecules—AVP—hypothyroidism	0.000254	0.00212	CbGpPWpGaD
Adinazolam—GABRG2—Transmembrane transport of small molecules—SLC5A5—hypothyroidism	0.000252	0.0021	CbGpPWpGaD
Adinazolam—GABRA6—Transmembrane transport of small molecules—AVP—hypothyroidism	0.00024	0.002	CbGpPWpGaD
Adinazolam—GABRA4—Transmembrane transport of small molecules—AVP—hypothyroidism	0.000237	0.00198	CbGpPWpGaD
Adinazolam—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—hypothyroidism	0.000227	0.00189	CbGpPWpGaD
Adinazolam—GABRA1—Transmembrane transport of small molecules—SLC5A5—hypothyroidism	0.00022	0.00184	CbGpPWpGaD
Adinazolam—GABRB2—Transmembrane transport of small molecules—AVP—hypothyroidism	0.000217	0.00181	CbGpPWpGaD
Adinazolam—GABRA5—Transmembrane transport of small molecules—AVP—hypothyroidism	0.000211	0.00176	CbGpPWpGaD
Adinazolam—GABRA3—Transmembrane transport of small molecules—AVP—hypothyroidism	0.000207	0.00172	CbGpPWpGaD
Adinazolam—GABRA2—Transmembrane transport of small molecules—AVP—hypothyroidism	0.000203	0.00169	CbGpPWpGaD
Adinazolam—GABRB3—Transmembrane transport of small molecules—AVP—hypothyroidism	0.000202	0.00168	CbGpPWpGaD
Adinazolam—GABRG2—Transmembrane transport of small molecules—AVP—hypothyroidism	0.000198	0.00165	CbGpPWpGaD
Adinazolam—CYP2C19—Metabolism—IYD—hypothyroidism	0.000191	0.00159	CbGpPWpGaD
Adinazolam—CYP3A4—Phase 1 - Functionalization of compounds—POMC—hypothyroidism	0.000184	0.00153	CbGpPWpGaD
Adinazolam—GABRA1—Transmembrane transport of small molecules—AVP—hypothyroidism	0.000173	0.00145	CbGpPWpGaD
Adinazolam—CYP2C19—Metabolism—ATP5O—hypothyroidism	0.000163	0.00136	CbGpPWpGaD
Adinazolam—CYP2C19—Biological oxidations—POMC—hypothyroidism	0.000162	0.00135	CbGpPWpGaD
Adinazolam—CYP2C19—Metabolism—TPO—hypothyroidism	0.000153	0.00127	CbGpPWpGaD
Adinazolam—CYP2C19—Metabolism of lipids and lipoproteins—PIK3C2A—hypothyroidism	0.000142	0.00118	CbGpPWpGaD
Adinazolam—CYP3A4—Metabolism—IYD—hypothyroidism	0.000115	0.000959	CbGpPWpGaD
Adinazolam—CYP3A4—Metabolism—ATP5O—hypothyroidism	9.79e-05	0.000815	CbGpPWpGaD
Adinazolam—CYP3A4—Biological oxidations—POMC—hypothyroidism	9.75e-05	0.000813	CbGpPWpGaD
Adinazolam—CYP3A4—Metabolism—TPO—hypothyroidism	9.2e-05	0.000767	CbGpPWpGaD
Adinazolam—CYP2C19—Metabolism—TSHB—hypothyroidism	7.08e-05	0.00059	CbGpPWpGaD
Adinazolam—CYP2C19—Metabolism—PIK3C2A—hypothyroidism	6.31e-05	0.000526	CbGpPWpGaD
Adinazolam—CYP2C19—Metabolism of lipids and lipoproteins—POMC—hypothyroidism	6.23e-05	0.000519	CbGpPWpGaD
Adinazolam—CYP2C19—Metabolism—SLC5A5—hypothyroidism	5.3e-05	0.000442	CbGpPWpGaD
Adinazolam—CYP3A4—Metabolism—TSHB—hypothyroidism	4.26e-05	0.000355	CbGpPWpGaD
Adinazolam—CYP3A4—Metabolism—PIK3C2A—hypothyroidism	3.8e-05	0.000316	CbGpPWpGaD
Adinazolam—CYP3A4—Metabolism—SLC5A5—hypothyroidism	3.19e-05	0.000266	CbGpPWpGaD
Adinazolam—CYP2C19—Metabolism—POMC—hypothyroidism	2.77e-05	0.000231	CbGpPWpGaD
Adinazolam—CYP3A4—Metabolism—POMC—hypothyroidism	1.67e-05	0.000139	CbGpPWpGaD
